·2,447,543篇论文数据,部分数据来源于NoteExpress
以上来源于: WordNet
This paper introduces the first, second and some new BCR-ABL tyrosine kinases inhibitors.
本文介绍了第一、二代以及新近开发的BCR - ABL酪氨酸激酶抑制剂。
But Gleevac, too, can be bypassed by further mutations of BCR-ABL which allow the tumour cells to grow in the presence of the drug.
但它无法阻止BCR - ABL产生进一步变异后的编码蛋白,即使在用药情况下肿瘤细胞仍不断扩张。
The results show that the level of GPT activity, BUN, BCr in blood of the rat which have been fed with DTC for 3 to 6 month are not markedly changed.
结果表明用DTC 饲养3至6个月大白鼠血中,其转氨酶活力,尿素氮、肌酐的水平没有明显变化。
应用推荐